Table 3.
Confirmed and probable ZIKV infection among healthy blood donors in Kota Kinabalu, Sabah, in 2017–2018
| IgM | Focus Reduction Neutralization Test (FRNT90) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample ID | ZIKV | DENV | JEV | ZIKV IgG titer | ZIKV | JEV | DENV-1 | DENV-2 | DENV-3 | DENV-4 | Diagnostic interpretation* |
| H-132 | 47.8 | 30.6 | 0.4 | 64,734 | 2,560 | < 20 | 640 | 640 | 640 | 160 | ZIKV |
| H-180 | 8.4 | 2.5 | 0.4 | 32,940 | 2,560 | < 20 | < 20 | 40 | 80 | 160 | ZIKV |
| H-207 | 57.4 | 7.9 | 0.4 | 63,740 | 2,560 | < 20 | 1280 | 640 | 320 | 160 | Probable |
| H-235 | 2.3 | 0.5 | 0.3 | 5,929 | 640 | 160 | 320 | 320 | < 20 | < 20 | Probable |
| H-241 | 7.9 | 2.0 | 0.8 | 14,092 | 640 | 40 | < 20 | 320 | < 20 | < 20 | Probable |
| H-248 | 51.6 | 21.4 | 9.2 | 38,050 | 5,120 | 2560 | 320 | 320 | 80 | 40 | Probable |
| H-257 | 4.4 | 2.4 | 0.5 | 60,874 | 5,120 | < 20 | 1280 | 1280 | 320 | < 20 | ZIKV |
| H-295 | 2.6 | 1.1 | 0.7 | 2,281 | 40 | < 20 | < 20 | < 20 | < 20 | < 20 | Probable |
| H-313 | 3.5 | 1.0 | 0.4 | 9,924 | 320 | < 20 | < 20 | < 20 | < 20 | < 20 | ZIKV |
| H-366 | 8.0 | 6.6 | 0.3 | 17,270 | 640 | < 20 | < 20 | < 20 | < 20 | < 20 | ZIKV |
| H-371 | 10.5 | 0.3 | 0.1 | 18,342 | 1,280 | < 20 | 40 | 320 | < 20 | < 20 | ZIKV |
| H-373 | 2.3 | 0.3 | 0.2 | 17,025 | 40 | < 20 | < 20 | < 20 | < 20 | < 20 | Probable |
DENV-1-4 = dengue virus serotype 1–4; Diagnosis interpretation* = ZIKV (confirmed ZIKV infection), Probable (probable ZIKV infection). Bold font indicates highest IgM and neutralization value in Table.